A phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of 2 dosing regimens of fostamatinib in patients with rheumatoid arthritis with an inadequate response to a tumor necrosis factor-α antagonist (Q46568872)
Jump to navigation
Jump to search
scientific article published on 15 September 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of 2 dosing regimens of fostamatinib in patients with rheumatoid arthritis with an inadequate response to a tumor necrosis factor-α antagonist |
scientific article published on 15 September 2014 |
Statements
1 reference
A phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of 2 dosing regimens of fostamatinib in patients with rheumatoid arthritis with an inadequate response to a tumor necrosis factor-α antagonist (English)
1 reference
Arthur Kavanaugh
1 reference
Mark C Genovese
1 reference
Désirée M van der Heijde
1 reference
Edward C Keystone
1 reference
Alberto J Spindler
1 reference
Claude Benhamou
1 reference
Edward Fudman
1 reference
Kathy Lampl
1 reference
Chris O'Brien
1 reference
Emma L Duffield
1 reference
Jeffrey Poiley
1 reference
Michael E Weinblatt
1 reference
15 September 2014
1 reference
41
1 reference
11
1 reference
2120-2128
1 reference
Identifiers
1 reference